IFRX
(NASDAQ)InflaRx N.V.
$2.17-- (--)
Loading... - Market loading
InflaRx (IFRX) Stock Price & Financial Analysis
InflaRx Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$2.11 - $2.26
52-Week High$2.95
52-Week Low$0.80
Open$2.19
Volume408.81K
Average Volume (3M)933.74K
Market Cap160.49M
Shares Outstanding72.29M
Price to Sales (P/S)4703.22
Price to Book (P/B)3.74
EV/EBITDA-3.02
Revenue (TTM)34.12K
Net Income (TTM)-49.92M
Free Cash Flow (TTM)-33.65M
EPS (TTM)$-0.73
Profit Margin-146303.90%
Operating Margin-144761.44%
Return on Equity (ROE)-116.20%
Debt to Equity0.02
50-Day MA$2.02
200-Day MA$1.51
52-Week Change37.34%
Annual Dividend$0.00
Dividend Yield0.00%
Day's Range$2.11 - $2.26
52-Week High$2.95
52-Week Low$0.80
Open$2.19
Volume408.81K
Average Volume (3M)933.74K
Market Cap160.49M
Shares Outstanding72.29M
Price to Sales (P/S)4703.22
Price to Book (P/B)3.74
EV/EBITDA-3.02
Revenue (TTM)34.12K
Net Income (TTM)-49.92M
Free Cash Flow (TTM)-33.65M
EPS (TTM)$-0.73
Profit Margin-146303.90%
Operating Margin-144761.44%
Return on Equity (ROE)-116.20%
Debt to Equity0.02
50-Day MA$2.02
200-Day MA$1.51
52-Week Change37.34%
Annual Dividend$0.00
Dividend Yield0.00%
Frequently Asked Questions About InflaRx
What is the current stock price for IFRX?
As of the latest trading session, IFRX stock trades at $2.17. The 52-week range is $0.80–$2.95, with a day range of $2.11–$2.26.
What is the P/E ratio for IFRX?
The P/E ratio (Price-to-Earnings) for IFRX is shown in the Key Statistics section. This valuation metric helps compare InflaRx N.V. to industry peers.
Does IFRX pay dividends?
InflaRx does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for IFRX?
Based on 1 analyst, the consensus for IFRX is Buy.
What is the market cap of IFRX?
InflaRx's market capitalization is $156.9M, classifying it as a micro-cap company. InflaRx operates in the Healthcare sector within the Biotechnology industry.